| LDR | | 00000cam k2200205 k 4500 |
| 001 | | 000000060205 |
| 005 | | 20240628023424 |
| 008 | | 140620s2013 us a 001a eng |
| 020 | |
▼a 0309269393 |
| 049 | |
▼a KIC
▼l 22661 |
| 090 | |
▼a 344.41041
▼b N277C |
| 245 | 0 |
▼a Countering the problem of falsified and substandard drugs /
▼d Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products;
▼e Board on Global Health ;
▼e Institute of Medicine ;
▼e Lawrence O. Gostin ;
▼e Gillian J. Buckley. |
| 260 | 0 |
▼a Washington, D.C:
▼b National Academies ,
▼c 2013. |
| 300 | |
▼a 351p. :
▼b ill. ;
▼c 24 cm. |
| 504 | |
▼a Includes bibliographical references |
| 650 | |
▼a Counterfeit Drugs |
| 650 | |
▼a Fraud--
▼v prevention & control |
| 650 | |
▼a Drug Contamination--
▼v prevention & control |
| 650 | |
▼a Pharmaceutical Preparations--
▼v standards |
| 650 | |
▼a Pharmaceutical industry--
▼x Quality control |
| 700 | 1 |
▼a Lawrence O. Gostin |
| 700 | 1 |
▼a Gillian J. Buckley |
| 710 | 1 |
▼a Institute of Medicine |
| 710 | 1 |
▼a Board on Global Health |